ACST.V
Price:
$0.58
Market Cap:
$47.91M
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Industry
Biotechnology
IPO Date
2011-03-31
Stock Exchange
TSXV
Ticker
ACST.V
According to Acasti Pharma Inc.’s latest financial reports and current stock price. The company's current ROE is -12.76%. This represents a change of 269.90% compared to the average of -3.45% of the last 4 quarters.
The mean historical ROE of Acasti Pharma Inc. over the last ten years is -98.45%. The current -12.76% ROE has changed -87.04% with respect to the historical average. Over the past ten years (40 quarters), ACST.V's ROE was at its highest in in the September 2019 quarter at 1.68%. The ROE was at its lowest in in the June 2019 quarter at -325.57%.
Average
-98.45%
Median
-29.28%
Minimum
-356.41%
Maximum
-4.98%
Discovering the peaks and valleys of Acasti Pharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.03%
Maximum Annual ROE = -4.98%
Minimum Annual Increase = -85.72%
Minimum Annual ROE = -356.41%
| Year | ROE | Change |
|---|---|---|
| 2025 | -14.36% | -31.00% |
| 2024 | -20.82% | -66.66% |
| 2023 | -62.44% | 588.47% |
| 2022 | -9.07% | -74.35% |
| 2021 | -35.35% | -81.99% |
| 2020 | -196.34% | -44.91% |
| 2019 | -356.41% | 36.30% |
| 2018 | -261.49% | 1.03% |
| 2016 | -23.21% | 365.90% |
| 2015 | -4.98% | -85.72% |
The current ROE of Acasti Pharma Inc. (ACST.V) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-32.54%
5-year avg
-28.41%
10-year avg
-98.45%
Acasti Pharma Inc.’s ROE is greater than Aeterna Zentaris Inc. (-149.40%), greater than Think Research Corporation (-60.78%), greater than MedMen Enterprises Inc. (-96.37%), greater than Reunion Neuroscience Inc. (-109.89%), less than Greenbrook TMS Inc. (1.57%), greater than HS GovTech Solutions Inc. (-131.26%), greater than IMV Inc. (-495.17%), greater than Vinergy Capital Inc. (-78.83%), greater than YourWay Cannabis Brands Inc. (-117.87%), less than IBEX Technologies Inc. (33.34%),
| Company | ROE | Market cap |
|---|---|---|
| -149.40% | $25.38M | |
| -60.78% | $24.82M | |
| -96.37% | $27.66M | |
| -109.89% | $16.64M | |
| 1.57% | $28.55M | |
| -131.26% | $29.01M | |
| -495.17% | $13.12M | |
| -78.83% | $20.18M | |
| -117.87% | $22.94M | |
| 33.34% | $35.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acasti Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acasti Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Acasti Pharma Inc.'s ROE?
How is the ROE calculated for Acasti Pharma Inc. (ACST.V)?
What is the highest ROE for Acasti Pharma Inc. (ACST.V)?
What is the 3-year average ROE for Acasti Pharma Inc. (ACST.V)?
What is the 5-year average ROE for Acasti Pharma Inc. (ACST.V)?
How does the current ROE for Acasti Pharma Inc. (ACST.V) compare to its historical average?